Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItm Power Regulatory News (ITM)

Share Price Information for Itm Power (ITM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.85
Bid: 53.70
Ask: 54.15
Change: 0.15 (0.28%)
Spread: 0.45 (0.838%)
Open: 55.95
High: 55.95
Low: 52.75
Prev. Close: 53.70
ITM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Progress Update

15 Sep 2010 07:00

RNS Number : 6845S
ITM Power PLC
15 September 2010
 



15 September 2010

 

ITM Power plc

("ITM Power" or "the Company")

 

Update on Progress, Launch of HFuel®

 

ITM Power (AIM: ITM) announces an Update on Progress ahead of the Company's Annual General Meeting and Shareholder Open Day taking place today.

 

Our HFuel® vehicle refueller is being launched today with the delivery, and demonstration, of the two hydrogen internal combustion engine Ford Transit vans from Revolve Technologies. The Hydrogen On Site Trials (HOST) involving these vehicles and the H-Fuel has gained significant commercial traction, with [seven] companies and local authorities already signed up. The trials will commence in 2011 and are the first step towards attracting high profile commercial and government customers for the technology.

 

We are now in the process of working towards CE certification for our products to enable their commercial sale in European markets. Four directives have been identified (Machinery, ATEX, EMC and Pressure Equipment) which together cover all four of the product platforms launched in April at the Hannover Messe: the HPac, HBox, HLab and HFlame. The Pressure Equipment Directive is particularly relevant to the HPac and HBox products which utilise Category II vessels. As announced on the 28th June 2010, we have been working with GASTEC at CRE (GaC) to address the requirements of these Directives. We are seeking voluntary Certificates of Conformity for the Machinery and EMC Directives from relevant UK Notified Bodies. The formal documentation for the pressure vessel in HPac has been submitted and is currently under consideration against the Pressure Equipment Directive.

 

We announced our first product sale and field trial, to the University of Birmingham, which will use our HPac10 product to supply hydrogen to its fuel cell laboratory, thus removing the facility's dependency on bottled gas. Separately, the Company signed a Memorandum of Understanding with Ballast Nedam Sustainability Services B.V, a Dutch construction and infrastructure development company, for the exclusive provision of hydrogen energy systems.

 

We have, in addition, made good progress on enhancing our technology. The goal of the core development work is to bring together performance, cost and longevity. These need to be achieved together, not in isolation. This goal is now well integrated into our product development and there have been significant achievements resulting in our technical base being stronger than ever. Several technical challenges remain and we are now structured to successfully tackle them. Technical achievements and progress include:

 

·; Major advancement in cell and stack design to enable high efficiency at full scale

·; MEA development has focused on minimising voltage rise and increasing mechanical strength, both of which have been improved by over 90% in the last 12 months

·; An experienced senior electrochemist has been recruited to the technical team

·; Commercially available MEA's are being used to benchmark cost and performance and qualify balance of plant

·; Infrastructure changes are underway to establish capacity for clean stack build and testing

·; An extensive product test programme is well underway which focuses on achievement of reliability evidence for all four product platforms

·; Relationships have been established with companies with whom volume production of product subsystems could be outsourced

 

We can also announce today the allowance of patents in Europe and Japan. These are important extensions to our substantial patent portfolio. The European Patent (Application number 05 077 932.1) is a divisional application to broaden the previously granted ITM Power materials and production processes related to electrochemical cells, and now covers the use of our materials in alternative, non energy related applications (unrestricted use). The Japanese Patent (Application Number 2003-527827) also builds on this position and has allowed the ITM Power materials in electrochemical cells and in a one-shot production process, and in other non-related applications (unrestricted use) reinforcing the Company's secure hold on its technology in this important territory. The grant of materials unrestricted to use now allows us to license our materials in alternative applications.

 

Creation and protection of relevant intellectual property remains central to our development strategy. We have robust processes to identify new intellectual property and seek the most appropriate method of protection. Our strategy has been to prosecute worldwide patent applications for the use of ITM Power's suite of unique materials and processes through the Patent Corporation Treaty. This has already been widely granted in other territories including the EU, US, China.

 

Through our involvement with the UKHA (UK Hydrogen Association), ITM Power is actively contributing to the development of future hydrogen technologies standards in the British Standards committee PVE 3/8 and in four International Standards Organisation (ISO) Technical Committee 197 Working Groups. We will attend forthcoming meetings in Tokyo next week for the residential electrolyser standard (ISO 22734-2) and hydrogen refueling station standard (ISO 20100), whilst also being involved in the hydrogen purity standards ISO 14687-2 and ISO 14687-3 for vehicular and stationary fuel cell applications respectively.

 

Looking forward, ITM Power retains significant cash reserves, of £16.9m, to fund commercialisation. These reserves will be supplemented by the successful application for grant monies from Government bodies including the Technology Strategy Board, which has allocated over £500,000 of grants to support our HydroGEN project to reduce the cost of alkaline membranes. In the current financial year, we have secured additional grant and research funding of £935,000, which will be received over the next 18 months.

 

In summary, the new management team, led by our Chief Executive Graham Cooley, has re-energised ITM Power over the last year. A new commercialisation strategy has been formulated and adopted and is being successfully prosecuted. The current financial year will see further milestones, with our first products commercially available and the commencement of the HOST trials with a number of blue chip companies and organisations. We will report further on progress to shareholders at the time of the half year results in January 2011.

 

For further information please visit www.itm-power.com or contact:

 

ITM Power plc

Graham Cooley, CEO

0114 244 5111

Panmure Gordon

Katherine Roe / Abhishek Majumdar

020 7459 3600

Tavistock Communications

Simon Hudson / James Midmer

020 7920 3150

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMKKQDKABKDCCD
Date   Source Headline
15th May 20244:43 pmRNSDirector/PDMR Shareholding
8th May 20246:00 pmRNSTotal Voting Rights
26th Apr 20247:00 amRNSPartnership with Hygen for industry growth
16th Apr 20241:32 pmRNSDirector/PDMR Shareholding
15th Mar 20244:00 pmRNSDirector/PDMR Shareholding
16th Feb 20244:00 pmRNSDirector/PDMR Shareholding
5th Feb 20244:00 pmRNSBlock listing Interim Review
31st Jan 20247:00 amRNSInterim Results
16th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSNotice of Interim Results and Presentation
15th Dec 20234:00 pmRNSDirector/PDMR Shareholding
11th Dec 20237:00 amRNS100MW Capacity Reservation
4th Dec 20237:00 amRNSTrading Update
15th Nov 20234:00 pmRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSLaunch of Hybrid Stack
30th Oct 20237:00 amRNSGrants under Long Term Incentive Plan
20th Oct 20237:00 amRNSITM announces completed sale of Motive Fuels Ltd
16th Oct 20237:00 amRNSEntry into the US market
13th Oct 20234:00 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSDirector/PDMR Shareholding
15th Sep 20234:00 pmRNSDirector/PDMR Shareholding
11th Sep 20234:30 pmRNSTotal Voting Rights
11th Sep 20234:30 pmRNSBlock listing Interim Review
1st Sep 20237:00 amRNSNotice of Annual General Meeting and Annual Report
17th Aug 20237:01 amRNSITM Power releases POSEIDON 20MW module
17th Aug 20237:00 amRNSITM Power PLC: Final Results
15th Aug 20234:00 pmRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSHeads of Terms for sale of Motive Fuels Ltd
26th Jul 20237:00 amRNSRoadmap for strategic collaboration with Gore
25th Jul 20237:00 amRNSUpdate on timing of FY23 results announcement
17th Jul 202311:00 amRNSITM Power contract award towards 100MW project
17th Jul 20239:46 amRNSDirector/PDMR Shareholding
10th Jul 20237:00 amRNSITM Power Expands in Germany
3rd Jul 20237:00 amRNSStrategic collaboration with Mott Corporation
30th Jun 20237:00 amRNSUKCA Accreditation Received
15th Jun 20234:00 pmRNSDirector/PDMR Shareholding
14th Jun 20234:00 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSTrading Update
16th May 20234:00 pmRNSDirector/PDMR Shareholding
17th Apr 20234:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSAdditional facilities at Bessemer Park
24th Mar 202312:33 pmRNSDirector/PDMR Shareholding
16th Mar 20234:00 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSExpanding test capacity
16th Feb 20235:00 pmRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSLTIP Grant
3rd Feb 20236:00 pmRNSBlock listing Interim Review
31st Jan 20237:00 amRNSInterim Results and Strategic Update
23rd Jan 20237:00 amRNSNotice of Interim Results
17th Jan 20234:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.